275 related articles for article (PubMed ID: 17932742)
21. Carcinoembryonic antigen in breast nipple aspirate fluid.
Foretova L; Garber JE; Sadowsky NL; Verselis SJ; Joseph DM; Andrade AF; Gudrais PG; Fairclough D; Li FP
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):195-8. PubMed ID: 9521431
[TBL] [Abstract][Full Text] [Related]
22. uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.
Qin W; Zhu W; Hewett JE; Rottinghaus G; Chen YC; Flynn JT; Kliethermes B; Mannello F; Sauter ER
BMC Cancer; 2008 Oct; 8():298. PubMed ID: 18922176
[TBL] [Abstract][Full Text] [Related]
23. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
[TBL] [Abstract][Full Text] [Related]
24. Patient variables that predict atypical cytology by nipple duct lavage.
Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
[TBL] [Abstract][Full Text] [Related]
26. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
[TBL] [Abstract][Full Text] [Related]
27. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer.
Varnum SM; Covington CC; Woodbury RL; Petritis K; Kangas LJ; Abdullah MS; Pounds JG; Smith RD; Zangar RC
Breast Cancer Res Treat; 2003 Jul; 80(1):87-97. PubMed ID: 12889602
[TBL] [Abstract][Full Text] [Related]
28. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
[TBL] [Abstract][Full Text] [Related]
29. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.
Euhus DM; Bu D; Ashfaq R; Xie XJ; Bian A; Leitch AM; Lewis CM
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1812-21. PubMed ID: 17855699
[TBL] [Abstract][Full Text] [Related]
30. Effects of high fruit-vegetable and/or low-fat intervention on breast nipple aspirate fluid micronutrient levels.
Djuric Z; Chen G; Ren J; Venkatramanamoorthy R; Covington CY; Kucuk O; Heilbrun LK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1393-9. PubMed ID: 17627004
[TBL] [Abstract][Full Text] [Related]
31. Lack of effect of celecoxib on prostaglandin E2 concentrations in nipple aspirate fluid from women at increased risk of breast cancer.
Sauter ER; Schlatter L; Hewett J; Koivunen D; Flynn JT
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1745-50. PubMed ID: 15533902
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of the inflammatory protein YKL-40 in precancers of the breast.
Qin W; Zhu W; Schlatter L; Miick R; Loy TS; Atasoy U; Hewett JE; Sauter ER
Int J Cancer; 2007 Oct; 121(7):1536-42. PubMed ID: 17565739
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L
Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
[TBL] [Abstract][Full Text] [Related]
34. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
Masood S
Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
[TBL] [Abstract][Full Text] [Related]
35. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
[TBL] [Abstract][Full Text] [Related]
36. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
[TBL] [Abstract][Full Text] [Related]
37. Influence of lactation history on breast nipple aspirate fluid yields and fluid composition.
Djuric Z; Visscher DW; Heilbrun LK; Chen G; Atkins M; Covington CY
Breast J; 2005; 11(2):92-9. PubMed ID: 15730453
[TBL] [Abstract][Full Text] [Related]
38. Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients.
Jespersen SS; Stovgaard ES; Nielsen D; Christensen TD; Buhl ASK; Christensen IJ; Balslev E
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):e5-e9. PubMed ID: 32217848
[TBL] [Abstract][Full Text] [Related]
39. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer.
Mannello F; Tonti GA; Pagliarani S; Benedetti S; Canestrari F; Zhu W; Qin W; Sauter ER
Int J Cancer; 2007 May; 120(9):1971-6. PubMed ID: 17266038
[TBL] [Abstract][Full Text] [Related]
40. The local hormonal environment and related biomarkers in the normal breast.
Khan SA; Bhandare D; Chatterton RT
Endocr Relat Cancer; 2005 Sep; 12(3):497-510. PubMed ID: 16172189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
